Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Pazoo, Inc. Set To Release First Pet Max Product: OxyMax H20

Stock quotes in this article: PZOO 

CEDAR KNOLLS, N.J., Jan. 15, 2013 /PRNewswire/ -- Pazoo, Inc. (OTCBB Symbol: PZOO (German WKN#: A1J3DK)) is pleased to announce that its Pet Max line of products for pets is set to be released ahead of schedule.  The first Pet Max product, the OxyMax H20, will be distributed to the largest private pet store chain in New England, Pet Life Stores, within the next 45 days. Pazoo expects to announce the release of 3 to 4 additional products from the Pet Max line by the second quarter of 2013.

OxyMax H20 is a physician formulated liquid containing oxygen that is easily dispensed through an eye dropper.  The liquid is mixed with an animal's everyday water and increases its energy by increasing the levels of oxygen in its blood.  OxyMax H20 also helps clean an animal's gums and teeth.  OxyMax H20 is safe for everyday use and has no known side effects.  Please see the product picture below as well as the label and ingredients.

(Logo: http://photos.prnewswire.com/prnh/20130115/NE42310 )

President of Pet Life, Pete Risano, said, "Here at Pet Life we are both honored and excited to be the first chain of stores to receive the Pet Max - OxyMax H2O and are looking forward to a long partnership with Pet Max."

CEO of Pazoo, Inc., David Cunic, said, "We are very excited about the release of OxyMax H20.  After the last several road shows and radio interviews, the buzz and the inquiries about our Pet Max line of products has been extremely positive.  We expect the OxyMax H20 product to be the start of many more successful products to come.  Here at Pazoo, we are all looking forward to getting the PetMax line in stores throughout the nation."

About Pazoo, Inc.:

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs